Skip to main content



commentary Commentary

Commentary: Unclear if COVID-19 vaccines prevent transmission but they remain valuable for controlling virus

The first SARS-CoV-2 vaccines have been shown to be highly effective at reducing disease, but we don’t know yet whether they induce sterilising immunity, says an observer.

Commentary: Unclear if COVID-19 vaccines prevent transmission but they remain valuable for controlling virus

A nurse prepares a dose of the Moderna COVID-19 vaccine, Jan 10, 2021, in the Bronx, New York. (AP Photo/Kevin Hagen)

CAMBRIDGE: Vaccines are a marvel of medicine. Few interventions can claim to have saved as many lives.

But it may surprise you to know that not all vaccines provide the same level of protection.

Some vaccines stop you getting symptomatic disease, but others stop you getting infected too. The latter is known as “sterilising immunity”.

With sterilising immunity, the virus can’t even gain a toehold in the body because the immune system stops the virus entering cells and replicating.

READ: Commentary: This 71-year-old wants you to get a COVID-19 vaccine once you can. Here’s why


There is a subtle yet important difference between preventing disease and preventing infection. 

A vaccine that “just” prevents disease might not stop you from transmitting the disease to others – even if you feel fine. But a vaccine that provides sterilising immunity stops the virus in its tracks.

In an ideal world, all vaccines would induce sterilising immunity. In reality, it is actually extremely difficult to produce vaccines that stop virus infection altogether. Most vaccines that are in routine use today do not achieve this.

READ: No corners cut in Singapore’s COVID-19 vaccine rollout: Expert panel doctor

READ: Worried about anaphylactic reactions and side effects? Experts answer FAQs on COVID-19 vaccination

For example, vaccines targeting rotavirus, a common cause of diarrhoea in infants, are only capable of preventing severe disease. But this has still proven invaluable in controlling the virus.

In the US, there has been almost 90 per cent fewer cases of rotavirus-associated hospital visits since the vaccine was introduced in 2006.

A similar situation occurs with the current poliovirus vaccines, yet there is hope this virus could be eradicated globally.

A health worker gives a polio vaccine to a child in Karachi, Pakistan, Tuesday, Dec. 1, 2020. The Pakistani government launched an anti-polio vaccination campaign in an effort to eradicate the crippling disease. (AP Photo/Fareed Khan)

The first SARS-CoV-2 vaccines to be licensed have been shown to be highly effective at reducing disease. Despite this, we don’t yet know whether these vaccines can induce sterilising immunity.

It is expected that data addressing this question will be available from the ongoing vaccine clinical trials soon. Although even if sterilising immunity is induced initially, this may change over time as immune responses wane and viral evolution occurs.

READ: Commentary: Here’s why taking the vaccine is necessary even if it’s optional


What would a lack of sterilising immunity mean for those vaccinated with the new COVID vaccines?

Quite simply it means that if you encounter the virus after vaccination, you may get infected but show no symptoms. This is because your vaccine-induced immune response is not able to stop every virus particle from replicating.

It is generally understood that a particular type of antibody known as a “neutralising antibody” is needed for sterilising immunity. These antibodies block virus entry into cells and prevent all replication.

READ: Commentary: How many people need to get a COVID-19 vaccine in order to stop the coronavirus?

However, the infecting virus may have to be identical to the vaccine virus in order to induce the perfect antibody.

Thankfully, our immune responses to vaccines involve many different cells and components of the immune system. Even if the antibody response isn’t optimal, other aspects of immune memory can kick in when the virus invades.

These include cytotoxic T cells and non-neutralising antibodies. Viral replication will be slowed and consequently disease reduced.

A woman gets an influenza vaccination while sitting inside a vehicle at a drive-through vaccine centre of a hospital in Goyang, South Korea, on Oct 26, 2020. (File photo: Reuters/Kim Hong-ji) FILE PHOTO: A woman gets an influenza vaccine sitting inside his vehicle at a drive-thru vaccine center of a hospital in Goyang, South Korea, October 26, 2020. REUTERS/Kim Hong-Ji

We know this from years of study on influenza vaccines. These vaccines typically induce protection from disease, but not necessarily protection from infection.

This is largely due to the different strains of influenza that circulate – a situation that may also occur with SARS-CoV-2. It is reassuring to note that flu vaccines, despite being unable to induce sterilising immunity, are still extremely valuable at controlling the virus.

READ: Commentary: Young or old first? Timing of COVID-19 vaccination could decide


In the absence of sterilising immunity, what effect might SARS-CoV-2 vaccines have on the spread of a virus through a population?

If asymptomatic infections are possible after vaccination, there has been concern that SARS-CoV-2 will simply continue to infect as many people as before. Is this possible?

Asymptomatically infected people typically produce virus at lower levels. Though there is not a perfect relationship, usually more virus equals more disease.

READ: Commentary: Pharmaceutical firms saved the world with COVID-19 vaccine in record time. But credit goes to others too

Therefore, vaccinated people are less likely to transmit enough virus to cause severe disease. This in turn means that the people getting infected in this situation are going to transmit less virus to the next susceptible person.

This has been neatly shown experimentally using a vaccine targeting a different virus in chickens; when only part of a flock was vaccinated, unvaccinated birds still showed milder disease and produced less virus.

So, while sterilising immunity is often the ultimate goal of vaccine design, it is rarely achieved.

Fortunately, this hasn’t stopped many different vaccines substantially reducing the number of cases of virus infections in the past. By reducing disease levels in individuals, this also reduces virus spread through populations, and this will hopefully bring the current pandemic under control.

Listen to experts break down the behind-the-scenes considerations and discussions going into what might be Singapore’s biggest vaccination programme ever:

BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak:​​​​​​

Sarah L Caddy is Clinical Research Fellow in Viral Immunology and Veterinary Surgeon at the University of Cambridge. This commentary first appeared on The Conversation.

Source: CNA/el


Also worth reading